Glenmark Pharmaceuticals Limited (GLENMARK)
Price | 802.80 -24.90 (-3.01%) | 52 Week High | 880.00 |
---|---|---|---|
ISIN | INE935A01035 | 52 Week Low | 363.65 |
Industry | Pharmaceuticals: Major | Volume | 6.4 M |
Sector | Health Technology | P/E Ratio TTM | 88.95 |
Market Cap | 233.6 B | 1 Year Beta | 1.25 |
Glenmark Pharmaceuticals Limited (GLENMARK) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1977 by Gracias Saldanha. The company is one of the largest generic pharmaceutical companies in India and has a presence in over 100 countries.
GLENMARK’s products include a wide range of generic pharmaceuticals, over-the-counter medicines, and active pharmaceutical ingredients (APIs). The company also has a growing portfolio of branded generics and biosimilars.
GLENMARK is a well-established company with a strong track record. The company has been consistently profitable for over 20 years and has a strong brand name in India and abroad. GLENMARK is also a leader in innovation, with a focus on developing new products and technologies.
Here are some of the key facts about GLENMARK:
- Incorporated in 1977
- Headquartered in Mumbai, India
- One of the largest generic pharmaceutical companies in India
- Presence in over 100 countries
- Products include generic pharmaceuticals, over-the-counter medicines, and APIs
- Growing portfolio of branded generics and biosimilars
- Well-established company with a strong track record
- Consistently profitable for over 20 years
- Strong brand name in India and abroad
- Leader in innovation
GLENMARK is a well-positioned company to capitalize on the growing demand for generic pharmaceuticals and APIs globally. The company has a strong track record, a diversified product portfolio, and a focus on innovation. However, investors should be aware of the risks involved in investing in a pharmaceutical company, such as the volatility of the pharmaceutical market and the risk of product recalls.
Glenmark Pharmaceuticals Limited (GLENMARK) Chart
Technical Analysis of Glenmark Pharmaceuticals Limited (GLENMARK)
Doji
Doji is formed on Glenmark Pharmaceuticals Limited (GLENMARK) in 1 Day Timeframe. Doji are used in technical analysis to help identify securities price patterns. A doji names a trading session in which a security has an open and close that are virtually equal, which resembles a candlestick on a chart. The word doji comes from the Japanese phrase meaning 'the same thing.' A doji candlestick is a neutral indicator that provides little information. They are rare, so they are not reliable for spotting things like price reversals. Doji formations come in three major types: gravestone, long-legged, and dragonfly.Moving Averages
Period | Simple | Exponential |
---|---|---|
MA 5 | 839.03 | 828.90 |
MA 10 | 832.45 | 826.15 |
MA 20 | 800.34 | 811.64 |
MA 30 | 793.36 | 799.17 |
MA 50 | 784.90 | 773.24 |
MA 100 | 704.52 | 708.19 |
MA 200 | 571.59 | 620.74 |
Moving Average Rating
Technical Indicators
Name | Value | Name | Value |
---|---|---|---|
Aroon Up (14) | 92.86 | Aroon Down (14) | 0.00 |
MACD Level (12, 26) | 18.98 | MACD Signal (12, 26) | 18.12 |
Relative Strength Index (7) | 40.18 | Relative Strength Index (14) | 49.98 |
Stochastic %D (14 3 3) | 73.93 | Stochastic %K (14 3 3) | 61.05 |
Stochastic RSI Fast (3, 3, 14, 14) | 40.81 | Stochastic RSI Slow (3, 3, 14, 14) | 63.03 |
Bollinger Upper Band (20) | 880.35 | Bollinger Lower Band (20) | 720.34 |
Keltner Channels Upper Band (20) | 874.85 | Keltner Channels Lower Band (20) | 748.44 |
Donchian Channels Upper Band (20) | 880.00 | Donchian Channels Lower Band (20) | 737.35 |
Ichimoku Conversion Line (9, 26, 52, 26) | 827.50 | Ichimoku Base Line (9, 26, 52, 26) | 808.67 |
Ichimoku Leading Span A (9, 26, 52, 26) | 780.34 | Ichimoku Leading Span B (9, 26, 52, 26) | 722.83 |
Positive Directional Indicator (14) | 24.31 | Negative Directional Indicator (14) | 22.53 |
Volume Weighted Average Price | 802.57 | Volume Weighted Moving Average 20 | 813.53 |
Oscillator Rating
Oscillators
Awesome Oscillator | 47.27 |
---|---|
Ultimate Oscillator (7,14,28) | 53.73 |
Money Flow (14) | 48.07 |
Chaikin Money Flow (20) | 0.16 |
Commodity Channel Index (20) | 6.42 |
Bull Bear Power | -38.19 |
High / Low
1 Month | 880.00 | 737.35 |
---|---|---|
3 Month | 880.00 | 628.00 |
6 Month | 880.00 | 424.00 |
52 Week | 880.00 | 363.65 |
All Time | 1,262.90 | 4.62 |
Volume
Volume | 6.4 M |
---|---|
Average 10 D | 2.5 M |
Average 30 D | 1.4 M |
Average 60 D | 1.3 M |
Average 90 D | 1.4 M |
Change/Volatility
Change | -24.90 (-3.01%) |
---|---|
Change 1W | -53.70 (-6.27%) |
Change 1M | 35.95 (4.69%) |
Volatility | 7.08 |
Volatility W | 5.11 |
Performance
Yesterday | 89.65 |
---|---|
Weekly | -7.30 |
Monthly | 5.22 |
3 Month | 27.88 |
6 Month | 85.38 |
Yearly | 111.26 |
5 Year | 21.88 |
All Time | 2,370.15 |
Misc.
Average Day Range (14) | 31.05 |
---|---|
Average Directional Index (14) | 29.82 |
Average True Range (14) | 29.28 |
Williams Percent Range (14) | -61.76 |
Rate Of Change (9) | 3.34 |
Hull Moving Average (9) | 832.21 |
Momentum (10) | 8.95 |
Parabolic SAR | 880.00 |
PIVOT POINTS of Glenmark Pharmaceuticals Limited (GLENMARK)
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Classic | 581.27 | 680.82 | 723.83 | 780.37 | 823.38 | 879.92 | 979.47 |
Fibonacci | 680.82 | 718.84 | 742.34 | 780.37 | 818.39 | 841.89 | 879.92 |
Camarilla | 739.47 | 748.60 | 757.72 | 780.37 | 775.98 | 785.10 | 794.23 |
Woodie's | 622.67 | 680.01 | 722.22 | 779.56 | 821.78 | 879.11 | 921.33 |
DeMark's | - | - | 702.32 | 769.61 | 801.88 | - | - |
Financial Analysis of Glenmark Pharmaceuticals Limited (GLENMARK)
Income Statement
Basic EPS (FY) | 10.53 |
---|---|
Basic EPS (TTM) | 9.02 |
EBITDA (Annual YoY Growth) | -1.92 |
EBITDA (Quarterly QoQ Growth) | 4.34 |
EBITDA (Quarterly YoY Growth) | 46.25 |
EBITDA (TTM) | 24.8 B |
EBITDA (TTM YoY Growth) | 13.76 |
EPS Diluted (Annual YoY Growth) | -68.44 |
EPS Diluted (FY) | 10.53 |
EPS Diluted (MRQ) | 7.10 |
EPS Diluted (Quarterly YoY Growth) | -22.12 |
EPS Diluted (TTM) | 9.02 |
EPS Diluted (TTM YoY Growth) | -69.23 |
EPS Forecast (MRQ) | 11.16 |
Free Cash Flow (Annual YoY Growth) | -448.54 |
Free Cash Flow Margin (FY) | -2.08 |
Gross Profit (Annual YoY Growth) | 2.24 |
Gross Profit (FY) | 43.3 B |
Gross Profit (MRQ) | 12.9 B |
Gross Profit (Quarterly QoQ Growth) | -6.38 |
Gross Profit (Quarterly YoY Growth) | 31.30 |
Gross Profit (TTM YoY Growth) | 10.66 |
Last Year Revenue (FY) | 129.9 B |
Revenue (Annual YoY Growth) | 5.57 |
Revenue per Employee (FY) | 8.7 M |
Revenue (Quarterly QoQ Growth) | 0.83 |
Revenue (Quarterly YoY Growth) | 22.48 |
Revenue (TTM YoY Growth) | 12.36 |
Net Income (Annual YoY Growth) | -68.44 |
Net Income (FY) | 3 B |
Net Income (Quarterly YoY Growth) | -22.12 |
Net Income (TTM YoY Growth) | -69.23 |
Total Revenue (FY) | 129.9 B |
Valuation
Enterprise Value/EBITDA (TTM) | 9.43 |
---|---|
Number of Employees | 14,965.00 |
Number of Shareholders | 285.5 T |
Shares Float | 138.4 M |
Price to Book (FY) | 2.39 |
Price to Earnings Ratio (TTM) | 88.95 |
Price to Revenue Ratio (TTM) | 1.66 |
Price to Sales (FY) | 1.74 |
Total Shares Outstanding | 282.2 M |
Research & development Ratio (FY) | 9.62 |
Selling & Admin expenses Ratio (FY) | 10.45 |
Selling & Admin expenses Ratio (TTM) | 18.86 |
Balance Sheet
Total Assets (Annual YoY Growth) | 13.40 |
---|---|
Total Debt (Annual YoY Growth) | 16.79 |
Total Liabilities (FY) | 95.3 B |
Cash & Equivalents (FY) | 14.7 B |
Cash and short term investments (FY) | 14.8 B |
Operating Metrics
Dividends
Dividend Yield Forward | 0.30 |
---|---|
Dividends Paid (FY) | -1,366,060,000.00 |
Dividends per Share (FY) | 2.50 |
Margins
Net Margin (FY) | 2.29 |
---|---|
Net Margin (TTM) | 1.87 |
Gross Margin (FY) | 33.37 |
Gross Margin (TTM) | 39.43 |
Operating Margin (FY) | 13.18 |
Operating Margin (TTM) | 13.65 |
Pretax Margin (TTM) | 5.83 |
Glenmark Pharmaceuticals Limited (GLENMARK) FUTURES
Expiry | Open | High | Low | Close | Settle | Contracts | Value | OI | OI Change |
---|---|---|---|---|---|---|---|---|---|
28-Sep-23 | 809.30 | 831.05 | 776.25 | 803.95 | 803.95 | 10.5 T | 122.1 T | 8.5 M | -445,150 |
26-Oct-23 | 814.10 | 834.85 | 781.50 | 808.45 | 808.45 | 2.2 T | 25.8 T | 1.3 M | 532.2 T |
30-Nov-23 | 810.00 | 834.60 | 787.40 | 814.95 | 814.95 | 59 | 693 | 59.5 T | 20.3 T |
Glenmark Pharmaceuticals Limited (GLENMARK) OPTIONS
Related Companies (Peers) to Glenmark Pharmaceuticals Limited (GLENMARK)
Price | 47.80 0.75 (1.59%) | 52 Week High | 55.90 |
---|---|---|---|
ISIN | INE198H01019 | 52 Week Low | 22.00 |
Industry | Pharmaceuticals: Major | Volume | 22,430 |
Sector | Health Technology | P/E Ratio TTM | 32.78 |
Market Cap | 1.2 B | 1 Year Beta | 0.24 |
Price | 552.35 -18.10 (-3.17%) | 52 Week High | 645.75 |
---|---|---|---|
ISIN | INE767A01016 | 52 Week Low | 313.90 |
Industry | Pharmaceuticals: Major | Volume | 292.3 T |
Sector | Health Technology | P/E Ratio TTM | 28.52 |
Market Cap | 52.8 B | 1 Year Beta | 0.50 |
Price | 432.00 -2.55 (-0.59%) | 52 Week High | 476.05 |
---|---|---|---|
ISIN | INE0LRU01027 | 52 Week Low | 234.80 |
Industry | Pharmaceuticals: Major | Volume | 188.6 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 39.4 B | 1 Year Beta | -0.07 |
Price | 22,543.25 -295.10 (-1.29%) | 52 Week High | 24,744.25 |
---|---|---|---|
ISIN | INE358A01014 | 52 Week Low | 17,481.80 |
Industry | Pharmaceuticals: Major | Volume | 9,333 |
Sector | Health Technology | P/E Ratio TTM | 46.33 |
Market Cap | 485.4 B | 1 Year Beta | -0.12 |
Price | 1,705.90 -16.80 (-0.98%) | 52 Week High | 1,904.45 |
---|---|---|---|
ISIN | INE031B01049 | 52 Week Low | 1,111.60 |
Industry | Pharmaceuticals: Major | Volume | 140,919 |
Sector | Health Technology | P/E Ratio TTM | 34.84 |
Market Cap | 216.6 B | 1 Year Beta | -0.30 |
Price | 749.10 6.70 (0.90%) | 52 Week High | 880.00 |
---|---|---|---|
ISIN | INE155C01010 | 52 Week Low | 505.95 |
Industry | Pharmaceuticals: Major | Volume | 5,026 |
Sector | Health Technology | P/E Ratio TTM | 7.38 |
Market Cap | 4.2 B | 1 Year Beta | 0.69 |
Price | 77.60 -0.90 (-1.15%) | 52 Week High | 87.60 |
---|---|---|---|
ISIN | INE426A01027 | 52 Week Low | 55.20 |
Industry | Pharmaceuticals: Major | Volume | 257.9 T |
Sector | Health Technology | P/E Ratio TTM | 7.86 |
Market Cap | 20.2 B | 1 Year Beta | 0.77 |
Price | 752.20 -12.65 (-1.65%) | 52 Week High | 826.75 |
---|---|---|---|
ISIN | INE901L01018 | 52 Week Low | 462.30 |
Industry | Pharmaceuticals: Major | Volume | 160.9 T |
Sector | Health Technology | P/E Ratio TTM | 27.98 |
Market Cap | 150.5 B | 1 Year Beta | 0.62 |
Price | 3,550.65 -101.20 (-2.77%) | 52 Week High | 4,243.00 |
---|---|---|---|
ISIN | INE540L01014 | 52 Week Low | 2,940.05 |
Industry | Pharmaceuticals: Major | Volume | 267.5 T |
Sector | Health Technology | P/E Ratio TTM | 37.13 |
Market Cap | 436.6 B | 1 Year Beta | 0.41 |
Price | 73.75 0.75 (1.03%) | 52 Week High | 85.90 |
---|---|---|---|
ISIN | INE385I01010 | 52 Week Low | 49.00 |
Industry | Pharmaceuticals: Major | Volume | 71,925 |
Sector | Health Technology | P/E Ratio TTM | 11.93 |
Market Cap | 1.5 B | 1 Year Beta | 0.69 |
Price | 1,278.65 11.00 (0.87%) | 52 Week High | 1,388.95 |
---|---|---|---|
ISIN | INE00FF01017 | 52 Week Low | 847.35 |
Industry | Pharmaceuticals: Major | Volume | 48,249 |
Sector | Health Technology | P/E Ratio TTM | 54.70 |
Market Cap | 46.2 B | 1 Year Beta | 0.35 |
Price | 878.95 1.10 (0.13%) | 52 Week High | 1,234.00 |
---|---|---|---|
ISIN | INE930P01018 | 52 Week Low | 570.00 |
Industry | Pharmaceuticals: Major | Volume | 150.6 T |
Sector | Health Technology | P/E Ratio TTM | 48.10 |
Market Cap | 94.4 B | 1 Year Beta | 0.22 |
Price | 4,583.80 66.00 (1.46%) | 52 Week High | 4,610.00 |
---|---|---|---|
ISIN | INE203A01020 | 52 Week Low | 2,911.00 |
Industry | Pharmaceuticals: Major | Volume | 11,341 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 112.8 B | 1 Year Beta | 0.28 |
Price | 464.75 26.60 (6.07%) | 52 Week High | 474.30 |
---|---|---|---|
ISIN | INE411U01027 | 52 Week Low | 275.70 |
Industry | Pharmaceuticals: Major | Volume | 1.7 M |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 12.1 B | 1 Year Beta | 0.99 |
Price | 93.45 0.10 (0.11%) | 52 Week High | 106.50 |
---|---|---|---|
ISIN | INE083D01012 | 52 Week Low | 63.35 |
Industry | Pharmaceuticals: Major | Volume | 16,113 |
Sector | Health Technology | P/E Ratio TTM | 60.88 |
Market Cap | 1.5 B | 1 Year Beta | -0.56 |
Price | 264.35 -2.65 (-0.99%) | 52 Week High | 299.15 |
---|---|---|---|
ISIN | INE376G01013 | 52 Week Low | 191.55 |
Industry | Pharmaceuticals: Major | Volume | 3.6 M |
Sector | Health Technology | P/E Ratio TTM | 75.62 |
Market Cap | 320.6 B | 1 Year Beta | 1.27 |
Price | 49.35 -0.20 (-0.40%) | 52 Week High | 65.00 |
---|---|---|---|
ISIN | INE829A01014 | 52 Week Low | 39.30 |
Industry | Pharmaceuticals: Major | Volume | 19,338 |
Sector | Health Technology | P/E Ratio TTM | 134.21 |
Market Cap | 806 M | 1 Year Beta | 0.64 |
Price | 91.90 0.10 (0.11%) | 52 Week High | 104.00 |
---|---|---|---|
ISIN | INE416D01022 | 52 Week Low | 69.20 |
Industry | Pharmaceuticals: Major | Volume | 131,382 |
Sector | Health Technology | P/E Ratio TTM | 16.19 |
Market Cap | 9.6 B | 1 Year Beta | 0.21 |
Price | 95.50 -1.95 (-2.00%) | 52 Week High | 127.55 |
---|---|---|---|
ISIN | INE650L01011 | 52 Week Low | 56.94 |
Industry | Pharmaceuticals: Major | Volume | 14,738 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 2.6 B | 1 Year Beta | 1.61 |
Price | 999.80 -3.60 (-0.36%) | 52 Week High | 1,127.90 |
---|---|---|---|
ISIN | INE475E01026 | 52 Week Low | 575.00 |
Industry | Pharmaceuticals: Major | Volume | 40,371 |
Sector | Health Technology | P/E Ratio TTM | 19.32 |
Market Cap | 76.3 B | 1 Year Beta | 0.55 |
Price | 167.65 -2.00 (-1.18%) | 52 Week High | 179.20 |
---|---|---|---|
ISIN | INE385W01011 | 52 Week Low | 80.00 |
Industry | Pharmaceuticals: Major | Volume | 2.3 M |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 26.6 B | 1 Year Beta | 0.37 |
Price | 3,705.05 -41.75 (-1.11%) | 52 Week High | 3,934.70 |
---|---|---|---|
ISIN | INE361B01024 | 52 Week Low | 2,730.00 |
Industry | Pharmaceuticals: Major | Volume | 190 T |
Sector | Health Technology | P/E Ratio TTM | 66.58 |
Market Cap | 994 B | 1 Year Beta | -0.06 |
Price | 5,517.05 -151.45 (-2.67%) | 52 Week High | 5,989.70 |
---|---|---|---|
ISIN | INE089A01023 | 52 Week Low | 4,089.30 |
Industry | Pharmaceuticals: Major | Volume | 489.6 T |
Sector | Health Technology | P/E Ratio TTM | 19.45 |
Market Cap | 943.8 B | 1 Year Beta | 0.21 |
Price | 812.00 0.25 (0.03%) | 52 Week High | 880.00 |
---|---|---|---|
ISIN | INE406M01024 | 52 Week Low | 551.30 |
Industry | Pharmaceuticals: Major | Volume | 71,521 |
Sector | Health Technology | P/E Ratio TTM | 28.89 |
Market Cap | 110.5 B | 1 Year Beta | 0.50 |
Price | 368.00 -1.50 (-0.41%) | 52 Week High | 428.95 |
---|---|---|---|
ISIN | INE258B01022 | 52 Week Low | 245.25 |
Industry | Pharmaceuticals: Major | Volume | 158.6 T |
Sector | Health Technology | P/E Ratio TTM | 26.18 |
Market Cap | 61.3 B | 1 Year Beta | 0.39 |
Price | 1,693.20 -1.65 (-0.10%) | 52 Week High | 2,238.00 |
---|---|---|---|
ISIN | INE068V01023 | 52 Week Low | 861.00 |
Industry | Pharmaceuticals: Major | Volume | 170.2 T |
Sector | Health Technology | P/E Ratio TTM | 37.38 |
Market Cap | 279 B | 1 Year Beta | 0.04 |
Price | 1,560.55 4.75 (0.31%) | 52 Week High | 1,624.00 |
---|---|---|---|
ISIN | INE159A01016 | 52 Week Low | 1,227.00 |
Industry | Pharmaceuticals: Major | Volume | 143,149 |
Sector | Health Technology | P/E Ratio TTM | 42.39 |
Market Cap | 263.2 B | 1 Year Beta | 0.13 |
Price | 645.00 18.80 (3.00%) | 52 Week High | 675.00 |
---|---|---|---|
ISIN | INE03Q201024 | 52 Week Low | 370.00 |
Industry | Pharmaceuticals: Major | Volume | 1.2 M |
Sector | Health Technology | P/E Ratio TTM | 16.01 |
Market Cap | 76.8 B | 1 Year Beta | 0.66 |
Price | 280.75 -5.65 (-1.97%) | 52 Week High | 333.00 |
---|---|---|---|
ISIN | INE742B01025 | 52 Week Low | 177.65 |
Industry | Pharmaceuticals: Major | Volume | 161.7 T |
Sector | Health Technology | P/E Ratio TTM | 34.33 |
Market Cap | 27.8 B | 1 Year Beta | 0.61 |
Price | 1,683.15 -4.90 (-0.29%) | 52 Week High | 2,275.00 |
---|---|---|---|
ISIN | INE782E01017 | 52 Week Low | 1,404.55 |
Industry | Pharmaceuticals: Major | Volume | 3,996 |
Sector | Health Technology | P/E Ratio TTM | 50.19 |
Market Cap | 14.3 B | 1 Year Beta | 0.50 |
Price | 300.35 -1.95 (-0.65%) | 52 Week High | 427.80 |
---|---|---|---|
ISIN | INE475B01022 | 52 Week Low | 260.75 |
Industry | Pharmaceuticals: Major | Volume | 251.1 T |
Sector | Health Technology | P/E Ratio TTM | 39.33 |
Market Cap | 37.3 B | 1 Year Beta | 1.03 |
Price | 85.65 -1.00 (-1.15%) | 52 Week High | 123.40 |
---|---|---|---|
ISIN | INE915B01019 | 52 Week Low | 52.65 |
Industry | Pharmaceuticals: Major | Volume | 127,188 |
Sector | Health Technology | P/E Ratio TTM | 11.00 |
Market Cap | 5.1 B | 1 Year Beta | 0.96 |
Price | 340.75 0.70 (0.21%) | 52 Week High | 423.90 |
---|---|---|---|
ISIN | INE873D01024 | 52 Week Low | 306.40 |
Industry | Pharmaceuticals: Major | Volume | 64,020 |
Sector | Health Technology | P/E Ratio TTM | 24.52 |
Market Cap | 31.3 B | 1 Year Beta | 1.71 |
Price | 894.25 -5.80 (-0.64%) | 52 Week High | 955.00 |
---|---|---|---|
ISIN | INE571A01038 | 52 Week Low | 669.80 |
Industry | Pharmaceuticals: Major | Volume | 474.1 T |
Sector | Health Technology | P/E Ratio TTM | 46.20 |
Market Cap | 228 B | 1 Year Beta | -0.16 |
Price | 1,377.70 -64.45 (-4.47%) | 52 Week High | 1,524.50 |
---|---|---|---|
ISIN | INE572A01028 | 52 Week Low | 875.00 |
Industry | Pharmaceuticals: Major | Volume | 208.5 T |
Sector | Health Technology | P/E Ratio TTM | 48.21 |
Market Cap | 222.5 B | 1 Year Beta | 0.43 |
Price | 429.25 -2.25 (-0.52%) | 52 Week High | 485.10 |
---|---|---|---|
ISIN | INE700A01033 | 52 Week Low | 268.90 |
Industry | Pharmaceuticals: Major | Volume | 95,625 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 68.8 B | 1 Year Beta | 0.75 |
Price | 249.05 11.80 (4.97%) | 52 Week High | 249.10 |
---|---|---|---|
ISIN | INE729D01010 | 52 Week Low | 125.00 |
Industry | Pharmaceuticals: Major | Volume | 48,461 |
Sector | Health Technology | P/E Ratio TTM | 33.11 |
Market Cap | 3.7 B | 1 Year Beta | 0.46 |
Price | 222.70 0.55 (0.25%) | 52 Week High | 253.00 |
---|---|---|---|
ISIN | INE082A01010 | 52 Week Low | 96.00 |
Industry | Pharmaceuticals: Major | Volume | 169.4 T |
Sector | Health Technology | P/E Ratio TTM | 47.91 |
Market Cap | 10.7 B | 1 Year Beta | 2.06 |
Price | 65.50 1.25 (1.95%) | 52 Week High | 125.50 |
---|---|---|---|
ISIN | INE268B01013 | 52 Week Low | 50.65 |
Industry | Pharmaceuticals: Major | Volume | 1,230 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 1.4 B | 1 Year Beta | 0.73 |
Price | 26.90 -0.10 (-0.37%) | 52 Week High | 40.00 |
---|---|---|---|
ISIN | INE670X01014 | 52 Week Low | 17.10 |
Industry | Pharmaceuticals: Major | Volume | 33,546 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 1.4 B | 1 Year Beta | 0.76 |
Price | 386.60 -4.10 (-1.05%) | 52 Week High | 533.50 |
---|---|---|---|
ISIN | INE947Q01028 | 52 Week Low | 278.85 |
Industry | Pharmaceuticals: Major | Volume | 1.4 M |
Sector | Health Technology | P/E Ratio TTM | 36.98 |
Market Cap | 210.4 B | 1 Year Beta | 0.37 |
Price | 501.05 -0.80 (-0.16%) | 52 Week High | 543.25 |
---|---|---|---|
ISIN | INE405C01035 | 52 Week Low | 275.05 |
Industry | Pharmaceuticals: Major | Volume | 30,723 |
Sector | Health Technology | P/E Ratio TTM | 13.05 |
Market Cap | 10.1 B | 1 Year Beta | 0.15 |
Price | 102.10 0.65 (0.64%) | 52 Week High | 158.50 |
---|---|---|---|
ISIN | INE584F01014 | 52 Week Low | 95.25 |
Industry | Pharmaceuticals: Major | Volume | 34,128 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 1.6 B | 1 Year Beta | 0.40 |
Price | 1,751.80 12.00 (0.69%) | 52 Week High | 1,949.00 |
---|---|---|---|
ISIN | INE634S01028 | 52 Week Low | 1,242.00 |
Industry | Pharmaceuticals: Major | Volume | 123,106 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 697.1 B | 1 Year Beta | 0.83 |
Price | 104.70 0.60 (0.58%) | 52 Week High | 122.50 |
---|---|---|---|
ISIN | INE750C01026 | 52 Week Low | 45.40 |
Industry | Pharmaceuticals: Major | Volume | 978.5 T |
Sector | Health Technology | P/E Ratio TTM | 15.93 |
Market Cap | 47 B | 1 Year Beta | 0.41 |
Price | 664.40 -3.50 (-0.52%) | 52 Week High | 1,078.00 |
---|---|---|---|
ISIN | INE646B01010 | 52 Week Low | 598.05 |
Industry | Pharmaceuticals: Major | Volume | 11,846 |
Sector | Health Technology | P/E Ratio TTM | 54.45 |
Market Cap | 8.5 B | 1 Year Beta | 1.20 |
Price | 70.25 -0.45 (-0.64%) | 52 Week High | 100.70 |
---|---|---|---|
ISIN | INE630Y01024 | 52 Week Low | 20.64 |
Industry | Pharmaceuticals: Major | Volume | 329.5 T |
Sector | Health Technology | P/E Ratio TTM | 71.06 |
Market Cap | 5.9 B | 1 Year Beta | 0.80 |
Price | 36.40 -0.10 (-0.27%) | 52 Week High | 48.45 |
---|---|---|---|
ISIN | INE083A01026 | 52 Week Low | 23.60 |
Industry | Pharmaceuticals: Major | Volume | 2.8 M |
Sector | Health Technology | P/E Ratio TTM | 39.02 |
Market Cap | 18.7 B | 1 Year Beta | 0.09 |
Price | 849.15 -10.80 (-1.26%) | 52 Week High | 928.00 |
---|---|---|---|
ISIN | INE987B01026 | 52 Week Low | 502.00 |
Industry | Pharmaceuticals: Major | Volume | 445.9 T |
Sector | Health Technology | P/E Ratio TTM | 18.91 |
Market Cap | 153.9 B | 1 Year Beta | 0.44 |
Price | 25.65 0.85 (3.43%) | 52 Week High | 30.90 |
---|---|---|---|
ISIN | INE023H01027 | 52 Week Low | 14.50 |
Industry | Pharmaceuticals: Major | Volume | 503.5 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 5.6 B | 1 Year Beta | 0.32 |
Price | 3,646.80 72.35 (2.02%) | 52 Week High | 4,340.00 |
---|---|---|---|
ISIN | INE794A01010 | 52 Week Low | 1,260.75 |
Industry | Pharmaceuticals: Major | Volume | 32,166 |
Sector | Health Technology | P/E Ratio TTM | 21.72 |
Market Cap | 45.8 B | 1 Year Beta | 1.21 |
Price | 2,006.85 29.90 (1.51%) | 52 Week High | 2,439.95 |
---|---|---|---|
ISIN | INE887E01022 | 52 Week Low | 1,175.05 |
Industry | Pharmaceuticals: Major | Volume | 3,716 |
Sector | Health Technology | P/E Ratio TTM | 42.77 |
Market Cap | 12.2 B | 1 Year Beta | 0.96 |
Price | 726.70 -11.05 (-1.50%) | 52 Week High | 909.00 |
---|---|---|---|
ISIN | INE234A01025 | 52 Week Low | 537.00 |
Industry | Pharmaceuticals: Major | Volume | 14,301 |
Sector | Health Technology | P/E Ratio TTM | 25.19 |
Market Cap | 18.1 B | 1 Year Beta | 0.77 |
Price | 510.50 -7.40 (-1.43%) | 52 Week High | 634.80 |
---|---|---|---|
ISIN | INE191A01027 | 52 Week Low | 305.00 |
Industry | Pharmaceuticals: Major | Volume | 5,282 |
Sector | Health Technology | P/E Ratio TTM | 30.24 |
Market Cap | 26.1 B | 1 Year Beta | 1.12 |
Price | 19.75 -0.15 (-0.75%) | 52 Week High | 30.35 |
---|---|---|---|
ISIN | INE749B01020 | 52 Week Low | 16.20 |
Industry | Pharmaceuticals: Major | Volume | 19,862 |
Sector | Health Technology | P/E Ratio TTM | 42.93 |
Market Cap | 158.2 M | 1 Year Beta | -0.30 |
Price | 156.80 1.45 (0.93%) | 52 Week High | 173.50 |
---|---|---|---|
ISIN | INE922B01023 | 52 Week Low | 107.00 |
Industry | Pharmaceuticals: Major | Volume | 1.4 M |
Sector | Health Technology | P/E Ratio TTM | 28.85 |
Market Cap | 9.5 B | 1 Year Beta | 0.19 |
Price | 3,857.95 26.05 (0.68%) | 52 Week High | 4,660.00 |
---|---|---|---|
ISIN | INE182A01018 | 52 Week Low | 3,408.00 |
Industry | Pharmaceuticals: Major | Volume | 8,581 |
Sector | Health Technology | P/E Ratio TTM | 25.77 |
Market Cap | 175.6 B | 1 Year Beta | 0.39 |
Price | 98.15 1.50 (1.55%) | 52 Week High | 176.28 |
---|---|---|---|
ISIN | INE0DK501011 | 52 Week Low | 61.63 |
Industry | Pharmaceuticals: Major | Volume | 3.6 M |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 118.1 B | 1 Year Beta | 1.65 |
Price | 4,862.80 -69.80 (-1.42%) | 52 Week High | 5,500.00 |
---|---|---|---|
ISIN | INE199A01012 | 52 Week Low | 3,870.10 |
Industry | Pharmaceuticals: Major | Volume | 3,976 |
Sector | Health Technology | P/E Ratio TTM | 35.18 |
Market Cap | 81.8 B | 1 Year Beta | 0.20 |
Price | 1,330.45 -6.30 (-0.47%) | 52 Week High | 1,361.00 |
---|---|---|---|
ISIN | INE105J01010 | 52 Week Low | 645.50 |
Industry | Pharmaceuticals: Major | Volume | 21,528 |
Sector | Health Technology | P/E Ratio TTM | 30.76 |
Market Cap | 22.1 B | 1 Year Beta | 0.90 |
Price | 326.25 3.05 (0.94%) | 52 Week High | 398.90 |
---|---|---|---|
ISIN | INE732S01012 | 52 Week Low | 185.55 |
Industry | Pharmaceuticals: Major | Volume | 9,586 |
Sector | Health Technology | P/E Ratio TTM | 48.32 |
Market Cap | 6.2 B | 1 Year Beta | 0.58 |
Price | 7,106.65 -41.70 (-0.58%) | 52 Week High | 7,590.00 |
---|---|---|---|
ISIN | INE058A01010 | 52 Week Low | 5,202.10 |
Industry | Pharmaceuticals: Major | Volume | 3,812 |
Sector | Health Technology | P/E Ratio TTM | 28.46 |
Market Cap | 164.6 B | 1 Year Beta | 0.28 |
Price | 88.35 -0.40 (-0.45%) | 52 Week High | 113.35 |
---|---|---|---|
ISIN | INE807F01027 | 52 Week Low | 61.80 |
Industry | Pharmaceuticals: Major | Volume | 653 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 22.1 B | 1 Year Beta | 0.08 |
Price | 355.30 3.85 (1.10%) | 52 Week High | 391.75 |
---|---|---|---|
ISIN | INE790G01031 | 52 Week Low | 222.60 |
Industry | Pharmaceuticals: Major | Volume | 258.6 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 30.5 B | 1 Year Beta | 0.43 |
Price | 382.70 -3.00 (-0.78%) | 52 Week High | 401.85 |
---|---|---|---|
ISIN | INE0D0K01014 | 52 Week Low | 219.80 |
Industry | Pharmaceuticals: Major | Volume | 248.5 T |
Sector | Health Technology | P/E Ratio TTM | 28.28 |
Market Cap | 11.9 B | 1 Year Beta | 0.57 |
Price | 122.20 0.95 (0.78%) | 52 Week High | 140.00 |
---|---|---|---|
ISIN | INE812G01025 | 52 Week Low | 54.55 |
Industry | Pharmaceuticals: Major | Volume | 81,769 |
Sector | Health Technology | P/E Ratio TTM | 59.74 |
Market Cap | 10.3 B | 1 Year Beta | 0.47 |
Price | 350.30 -6.40 (-1.79%) | 52 Week High | 495.00 |
---|---|---|---|
ISIN | INE624Z01016 | 52 Week Low | 322.90 |
Industry | Pharmaceuticals: Major | Volume | 76,108 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 12.8 B | 1 Year Beta | 0.49 |
Price | 498.75 11.65 (2.39%) | 52 Week High | 522.75 |
---|---|---|---|
ISIN | INE939A01011 | 52 Week Low | 268.15 |
Industry | Pharmaceuticals: Major | Volume | 815.8 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 44.1 B | 1 Year Beta | 0.67 |
Price | 225.30 -2.30 (-1.01%) | 52 Week High | 265.85 |
---|---|---|---|
ISIN | INE232I01014 | 52 Week Low | 162.10 |
Industry | Pharmaceuticals: Major | Volume | 265.5 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 74 B | 1 Year Beta | 1.48 |
Price | 1,132.35 -13.80 (-1.20%) | 52 Week High | 1,169.70 |
---|---|---|---|
ISIN | INE044A01036 | 52 Week Low | 892.05 |
Industry | Pharmaceuticals: Major | Volume | 1.6 M |
Sector | Health Technology | P/E Ratio TTM | 32.21 |
Market Cap | 2.7 T | 1 Year Beta | 0.29 |
Price | 277.25 -4.05 (-1.44%) | 52 Week High | 334.00 |
---|---|---|---|
ISIN | INE07RO01027 | 52 Week Low | 170.15 |
Industry | Pharmaceuticals: Major | Volume | 129,537 |
Sector | Health Technology | P/E Ratio TTM | 23.96 |
Market Cap | 22.6 B | 1 Year Beta | 1.05 |
Price | 73.40 1.80 (2.51%) | 52 Week High | 82.20 |
---|---|---|---|
ISIN | INE495B01038 | 52 Week Low | 45.00 |
Industry | Pharmaceuticals: Major | Volume | 645.2 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 15.5 B | 1 Year Beta | 1.05 |
Price | 8.60 0.10 (1.18%) | 52 Week High | 11.60 |
---|---|---|---|
ISIN | INE312C01025 | 52 Week Low | 4.60 |
Industry | Pharmaceuticals: Major | Volume | 1.2 M |
Sector | Health Technology | P/E Ratio TTM | 39.23 |
Market Cap | 8 B | 1 Year Beta | -0.23 |
Price | 1,723.10 26.80 (1.58%) | 52 Week High | 1,801.85 |
---|---|---|---|
ISIN | INE083B01016 | 52 Week Low | 877.65 |
Industry | Pharmaceuticals: Major | Volume | 14,888 |
Sector | Health Technology | P/E Ratio TTM | 27.53 |
Market Cap | 15.7 B | 1 Year Beta | 1.20 |
Price | 1,850.40 -24.00 (-1.28%) | 52 Week High | 2,094.55 |
---|---|---|---|
ISIN | INE685A01028 | 52 Week Low | 1,445.55 |
Industry | Pharmaceuticals: Major | Volume | 498.7 T |
Sector | Health Technology | P/E Ratio TTM | 49.70 |
Market Cap | 634.5 B | 1 Year Beta | 0.30 |
Price | 1,162.95 -12.00 (-1.02%) | 52 Week High | 1,474.00 |
---|---|---|---|
ISIN | INE910C01018 | 52 Week Low | 828.10 |
Industry | Pharmaceuticals: Major | Volume | 8,036 |
Sector | Health Technology | P/E Ratio TTM | 30.14 |
Market Cap | 16.6 B | 1 Year Beta | 0.26 |
Price | 417.35 -4.00 (-0.95%) | 52 Week High | 466.95 |
---|---|---|---|
ISIN | INE351A01035 | 52 Week Low | 264.80 |
Industry | Pharmaceuticals: Major | Volume | 44,480 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 29.6 B | 1 Year Beta | 1.43 |
Price | 120.50 -1.05 (-0.86%) | 52 Week High | 193.75 |
---|---|---|---|
ISIN | INE972X01014 | 52 Week Low | 91.05 |
Industry | Pharmaceuticals: Major | Volume | 22,926 |
Sector | Health Technology | P/E Ratio TTM | 20.48 |
Market Cap | 1.3 B | 1 Year Beta | -0.45 |
Price | 62.60 1.15 (1.87%) | 52 Week High | 70.95 |
---|---|---|---|
ISIN | INE107F01022 | 52 Week Low | 33.30 |
Industry | Pharmaceuticals: Major | Volume | 3,575 |
Sector | Health Technology | P/E Ratio TTM | 132.68 |
Market Cap | 2 B | 1 Year Beta | 0.99 |
Price | 349.50 -3.95 (-1.12%) | 52 Week High | 420.90 |
---|---|---|---|
ISIN | INE0H5O01029 | 52 Week Low | 212.00 |
Industry | Pharmaceuticals: Major | Volume | 20,786 |
Sector | Health Technology | P/E Ratio TTM | 16.65 |
Market Cap | 7.4 B | 1 Year Beta | 0.74 |
Price | 227.40 -4.40 (-1.90%) | 52 Week High | 269.10 |
---|---|---|---|
ISIN | INE049B01025 | 52 Week Low | 145.15 |
Industry | Pharmaceuticals: Major | Volume | 951.2 T |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 33.1 B | 1 Year Beta | 0.97 |
Price | 396.75 6.05 (1.55%) | 52 Week High | 495.00 |
---|---|---|---|
ISIN | INE358U01012 | 52 Week Low | 251.00 |
Industry | Pharmaceuticals: Major | Volume | 27,139 |
Sector | Health Technology | P/E Ratio TTM | |
Market Cap | 9.8 B | 1 Year Beta | 0.02 |
Price | 595.60 -20.05 (-3.26%) | 52 Week High | 668.75 |
---|---|---|---|
ISIN | INE010B01027 | 52 Week Low | 350.25 |
Industry | Pharmaceuticals: Major | Volume | 1.6 M |
Sector | Health Technology | P/E Ratio TTM | 23.84 |
Market Cap | 623.1 B | 1 Year Beta | 0.36 |
Glenmark Pharmaceuticals Limited (GLENMARK) Related Indices
News Related to Glenmark Pharmaceuticals Limited (GLENMARK)
Sep 22, 2023, 9:43 pm
Glenmark Pharma stock falls on stake sale in Glenmark Life Sciences Glenmark Pharma stock fell after the company announced it would sell a 75% stake in its subsidiary Glenmark Life Sciences to Nirma. Analysts expect the stake sale to benefit Glenmark Pharma, as it will transition from a net debt position to a cash surplus position. This is expected to have a positive impact on the company's return ratios over the next two to three years.
Sep 21, 2023, 9:20 pm
Glenmark Life Sciences shares up 1% on reports of Glenmark Pharma stake sale Glenmark Life Sciences shares were up over 1% in the afternoon trade on September 21 after reports that parent Glenmark Pharmaceuticals was looking to reduce its stake in the company. Glenmark Pharmaceuticals is required to reduce its stake to 75% by August 2024 to comply with SEBI regulations. Nirma and ChrysCapital have both submitted binding bids for Glenmark Pharmaceuticals' stake in Glenmark Life Sciences. In the April-to-June quarter, Glenmark Life Sciences reported an 18% YoY growth in revenue and a 24% YoY increase in net profit.
Stock Sectors
- 52Commercial Services
- 13Communications
- 72Consumer Durables
- 111Consumer Non-Durables
- 81Consumer Services
- 33Distribution Services
- 49Electronic Technology
- 18Energy Minerals
- 245Finance
- 20Health Services
- 95Health Technology
- 85Industrial Services
- 2Miscellaneous
- 134Non-Energy Minerals
- 357Process Industries
- 270Producer Manufacturing
- 31Retail Trade
- 103Technology Services
- 41Transportation
- 38Utilities
Stock Industries
- 3Advertising/Marketing Services
- 7Aerospace & Defense
- 62Agricultural Commodities/Milling
- 14Air Freight/Couriers
- 3Airlines
- 6Alternative Power Generation
- 4Aluminum
- 39Apparel/Footwear
- 9Apparel/Footwear Retail
- 64Auto Parts: OEM
- 11Automotive Aftermarket
- 9Beverages: Alcoholic
- 1Beverages: Non-Alcoholic
- 1Biotechnology
- 12Broadcasting
- 17Building Products
- 4Cable/Satellite TV
- 1Catalog/Specialty Distribution
- 40Chemicals: Agricultural
- 18Chemicals: Major Diversified
- 75Chemicals: Specialty
- 3Coal
- 4Commercial Printing/Forms
- 1Computer Communications
- 4Computer Peripherals
- 37Construction Materials
- 3Consumer Sundries
- 25Containers/Packaging
- 2Contract Drilling
- 5Data Processing Services
- 1Department Stores
- 1Drugstore Chains
- 25Electric Utilities
- 46Electrical Products
- 3Electronic Components
- 9Electronic Equipment/Instruments
- 11Electronic Production Equipment
- 4Electronics Distributors
- 1Electronics/Appliance Stores
- 9Electronics/Appliances
- 75Engineering & Construction
- 1Environmental Services
- 55Finance/Rental/Leasing
- 28Financial Conglomerates
- 3Financial Publishing/Services
- 3Food Distributors
- 3Food Retail
- 7Food: Major Diversified
- 7Food: Meat/Fish/Dairy
- 28Food: Specialty/Candy
- 9Forest Products
- 7Gas Distributors
- 10Home Furnishings
- 1Home Improvement Chains
- 7Homebuilding
- 13Hospital/Nursing Management
- 18Hotels/Resorts/Cruise lines
- 14Household/Personal Care
- 9Industrial Conglomerates
- 51Industrial Machinery
- 35Industrial Specialties
- 54Information Technology Services
- 3Integrated Oil
- 7Internet Retail
- 11Internet Software/Services
- 43Investment Banks/Brokers
- 16Investment Managers
- 1Investment Trusts/Mutual Funds
- 6Life/Health Insurance
- 18Major Banks
- 6Major Telecommunications
- 6Marine Shipping
- 1Medical Distributors
- 2Medical Specialties
- 7Medical/Nursing Services
- 32Metal Fabrication
- 1Miscellaneous
- 39Miscellaneous Commercial Services
- 24Miscellaneous Manufacturing
- 14Motor Vehicles
- 21Movies/Entertainment
- 4Multi-Line Insurance
- 3Office Equipment/Supplies
- 1Oil & Gas Pipelines
- 1Oil & Gas Production
- 11Oil Refining/Marketing
- 6Oilfield Services/Equipment
- 7Other Consumer Services
- 20Other Consumer Specialties
- 19Other Metals/Minerals
- 10Other Transportation
- 33Packaged Software
- 3Personnel Services
- 2Pharmaceuticals: Generic
- 84Pharmaceuticals: Major
- 6Pharmaceuticals: Other
- 1Precious Metals
- 4Publishing: Books/Magazines
- 7Publishing: Newspapers
- 18Pulp & Paper
- 1Railroads
- 51Real Estate Development
- 22Regional Banks
- 8Restaurants
- 3Semiconductors
- 2Specialty Insurance
- 7Specialty Stores
- 5Specialty Telecommunications
- 64Steel
- 11Telecommunications Equipment
- 84Textiles
- 3Tobacco
- 1Tools & Hardware
- 7Trucking
- 24Trucks/Construction/Farm Machinery
- 25Wholesale Distributors
- 2Wireless Telecommunications
Leave a Reply